RE: Exit Strategy25 Jan 2021 14:11
Given the precarious position the world is in today, and whilst I agree with the £29 synopsis, I cant help thinking that IF we get an EUA from the FDA before the end of March, we will be in a truly unique position. I suspect with cash rolling in from stock piling orders, large pharma co's will be falling over themselves to get a piece of the action. However, we will be in a very strong negotiation position. My personal target is £25 a share.
With the strong potential to increase treatments from 100,0000 to many multiples of that, I can see £50 a share in the medium term. Getting this distributed across the world will require a large pharma or large specialist distributor. A distributor may well be happy to take a lower margin....time will tell.